National Health (Remote Aboriginal Health Services Program) Special Arrangements Amendment Instrument 2014 (No. 2) (No. PB 99 of 2014)

Overview

The National Health (Remote Aboriginal Health Services Program) Special Arrangements Amendment Instrument 2014 (No. 2) amends the National Health Act 1953 to address a specific gap in the existing legislative framework concerning the approval of pharmacists for the supply of pharmaceutical benefits under the Remote Aboriginal Health Services Program. Enacted by the Australian Parliament, this instrument seeks to refine the conditions for the approval of pharmacists to ensure more effective and culturally sensitive healthcare delivery in remote Aboriginal communities. The policy objective is to facilitate better access to essential medications by pharmacists who serve these communities, thereby improving health outcomes. The Minister for Health, exercising powers under the National Health Act 1953, introduced this amendment to exclude certain conditions relating to the approval of pharmacists from applying in circumstances specific to the Remote Aboriginal Health Services Program. This legislative change aims to streamline the approval process for pharmacists in these remote areas, ensuring that the unique needs and logistical challenges faced by these communities are adequately considered, ultimately contributing to more efficient and accessible healthcare services.

Scope and Application

The National Health (Remote Aboriginal Health Services Program) Special Arrangements Amendment Instrument 2014 (No. 2) amends the National Health (Remote Aboriginal Health Services Program) Special Arrangements Instrument 2010 to modify the conditions under which pharmaceutical benefits are supplied to remote Aboriginal Health Services. This legislative instrument applies to approved pharmacists and the entities they serve within the context of the Remote Aboriginal Health Services Program. The changes primarily affect the conditions of approval for pharmacists involved in the supply of pharmaceutical benefits to remote Aboriginal Health Services. These amendments exclude certain conditions from applying to the supply of pharmaceutical benefits under this special arrangement, thereby providing flexibility in the administration and operation of the program. This amendment has a Commonwealth reach, as it pertains to the supply of pharmaceutical benefits under the National Health Act 1953. The Instrument excludes specific conditions relating to the approval of pharmacists from applying in the context of supplies made under the Remote Aboriginal Health Services Program, thereby providing a tailored approach to the unique needs of remote Aboriginal communities. The changes are minor and do not involve consultations with stakeholders.

Key Provisions

The National Health (Remote Aboriginal Health Services Program) Special Arrangements Amendment Instrument 2014 (No. 2) amends the National Health (Remote Aboriginal Health Services Program) Special Arrangements Instrument 2010 (PB 65 of 2010) to modify the conditions for approving pharmacists involved in supplying pharmaceutical benefits under the Remote Aboriginal Health Services Program. This change aims to streamline the approval process for pharmacists supplying these services by excluding certain conditions from applying in this context. The amendment introduces a new section, section 10, which specifies that subsection 8(3) of the conditions for approving pharmacists, as stipulated under paragraph 92A(1)(f) of the National Health Act 1953, does not apply when supplying pharmaceutical benefits under the Remote Aboriginal Health Services Program. This amendment seeks to address potential barriers in the supply of pharmaceutical benefits to remote Aboriginal Health Services by simplifying the pharmacist approval process. Under this amended arrangement, entities or individuals involved in supplying pharmaceutical benefits to remote Aboriginal Health Services must comply with the new conditions specified in section 10. This means that pharmacists supplying drugs under the Remote Aboriginal Health Services Program will not be subject to the conditions outlined in subsection 8(3) of the approval criteria. Such compliance ensures that the supply of essential pharmaceutical benefits can be facilitated more efficiently, thereby improving access to healthcare for remote Aboriginal communities. These changes are intended to support the smooth operation of the program by making it easier for qualified pharmacists to participate. Breaches of the conditions set out in the amended arrangement may have legal consequences, although the specific penalties are not detailed in the explanatory statement. Generally, under the National Health Act 1953, non-compliance with the Act’s provisions can result in both civil and criminal penalties. Civil penalties can include fines, while criminal penalties can include imprisonment, depending on the nature and severity of the breach. For example, supplying pharmaceutical benefits in a manner that contravenes the Act could result in fines up to a certain amount, and in more serious cases, imprisonment for a specified term. It is important for entities and individuals to adhere to the conditions outlined in the Act and the amended arrangement to avoid any potential legal repercussions.